Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.32B |
| 2 |
Amazon
AMZN
|
+$827M |
| 3 |
Visa
V
|
+$530M |
| 4 |
Johnson & Johnson
JNJ
|
+$454M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$451M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.29B |
| 2 |
Uber
UBER
|
+$1.94B |
| 3 |
CELG
Celgene Corp
CELG
|
+$740M |
| 4 |
Alibaba
BABA
|
+$737M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$561M |
Sector Composition
| 1 | Technology | 15.2% |
| 2 | Financials | 12.2% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Communication Services | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Nice
NICE
$8.82B
| $16.8M | ﹤0.01% |
108,483
+43,518
| +67% | +$6.75M |
|
1727
Central Garden & Pet Class A
CENTA
$2.03B
| $16.8M | ﹤0.01% |
715,588
+139,562
| +24% | +$3.28M |
|
1728
Natural Resource Partners
NRP
$1.34B
| $16.8M | ﹤0.01% |
835,273
| – | – |
|
1729
Helen of Troy
HELE
$554M
| $16.8M | ﹤0.01% |
93,367
+12,715
| +16% | +$2.29M |
|
|
DRNA
1730
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $16.8M | ﹤0.01% |
760,878
-22,139
| -3% | -$488K |
|
1731
Simmons First National
SFNC
$2.96B
| $16.7M | ﹤0.01% |
621,896
+17,240
| +3% | +$462K |
|
1732
Supernus Pharmaceuticals
SUPN
$2.55B
| $16.6M | ﹤0.01% |
699,013
+378,809
| +118% | +$8.99M |
|
1733
Standex International
SXI
$2.47B
| $16.6M | ﹤0.01% |
208,786
+4,083
| +2% | +$324K |
|
1734
Amalgamated Financial
AMAL
$859M
| $16.6M | ﹤0.01% |
851,638
-329,628
| -28% | -$6.41M |
|
1735
Glaukos
GKOS
$4.75B
| $16.5M | ﹤0.01% |
303,718
+38,918
| +15% | +$2.12M |
|
1736
iShares Russell Mid-Cap Value ETF
IWS
$14.2B
| $16.5M | ﹤0.01% |
174,010
+11,488
| +7% | +$1.09M |
|
1737
Pacific Biosciences
PACB
$351M
| $16.5M | ﹤0.01% |
3,202,123
-19,827
| -0.6% | -$102K |
|
1738
Griffon
GFF
$3.61B
| $16.4M | ﹤0.01% |
807,494
+81,024
| +11% | +$1.65M |
|
1739
iShares US Pharmaceuticals ETF
IHE
$578M
| $16.4M | ﹤0.01% |
307,014
-1,350,000
| -81% | -$72.1M |
|
1740
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.01B
| $16.3M | ﹤0.01% |
+323,023
| New | +$16.3M |
|
1741
iShares MSCI Philippines ETF
EPHE
$103M
| $16.3M | ﹤0.01% |
475,000
-29,454
| -6% | -$1.01M |
|
1742
Canadian Solar
CSIQ
$729M
| $16.3M | ﹤0.01% |
736,546
+295,027
| +67% | +$6.52M |
|
1743
iShares US Healthcare ETF
IYH
$2.76B
| $16.3M | ﹤0.01% |
377,290
| – | – |
|
1744
Sprouts Farmers Market
SFM
$13.3B
| $16.2M | ﹤0.01% |
837,716
-234,419
| -22% | -$4.54M |
|
1745
B2Gold
BTG
$5.94B
| $16.2M | ﹤0.01% |
4,027,778
-669,163
| -14% | -$2.68M |
|
1746
BlackLine
BL
$3.36B
| $16.1M | ﹤0.01% |
312,667
+68,368
| +28% | +$3.53M |
|
1747
Codexis
CDXS
$219M
| $16.1M | ﹤0.01% |
1,005,026
+85,181
| +9% | +$1.36M |
|
1748
Anika Therapeutics
ANIK
$125M
| $16.1M | ﹤0.01% |
309,876
+138,695
| +81% | +$7.19M |
|
1749
Halozyme
HALO
$8.99B
| $16M | ﹤0.01% |
904,214
-699,487
| -44% | -$12.4M |
|
1750
SPDR S&P International Dividend ETF
DWX
$495M
| $16M | ﹤0.01% |
398,373
+4,280
| +1% | +$172K |
|